Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection.

Millie D LongXian ZhangJames D LewisGil Y MelmedCorey Allan SiegelEmily CercielloAngela DobesAlandra WeaverLaura WeisbeinMichael D Kappelman

Published in: Crohn's & colitis 360 (2022)

Immunosuppression use did not increase the risk of development of COVID-19. Therapeutic management of IBD should not be altered to prevent a risk of developing COVID-19.

Keyphrases

coronavirus disease
sars cov
patients with inflammatory bowel disease
respiratory syndrome coronavirus
cardiovascular disease
type diabetes
human health